[(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate

C32H52O5 — CID 155521423

IUPAC[(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate
SMILESCC(=O)O[C@H]([C@@H](O)C[C@@H](C)C1=C2CC[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)C(C)(C)O
InChIInChI=1S/C32H52O5/c1-19(18-23(34)27(29(5,6)36)37-20(2)33)21-12-16-31(8)22(21)10-11-25-30(7)15-14-26(35)28(3,4)24(30)13-17-32(25,31)9/h19,23-25,27,34,36H,10-18H2,1-9H3/t19-,23+,24+,25+,27-,30+,31+,32+/m1/s1
InChIKeyYXPPAEOSVBKNSF-PVDPLZRQSA-N
MW516.76 g/mol
LogP6.39
Rot. Bonds6

About [(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate

[(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate (PubChem CID 155521423) has the molecular formula C32H52O5 and a molecular weight of 516.76 g/mol. Its IUPAC name is [(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate.

Molecular Properties

Compound Name[(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate
PubChem CID155521423
Molecular FormulaC32H52O5
Molecular Weight516.76 g/mol
Exact Mass516.38
IUPAC Name[(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate
SMILESCC(=O)O[C@H]([C@@H](O)C[C@@H](C)C1=C2CC[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)C(C)(C)O
InChIInChI=1S/C32H52O5/c1-19(18-23(34)27(29(5,6)36)37-20(2)33)21-12-16-31(8)22(21)10-11-25-30(7)15-14-26(35)28(3,4)24(30)13-17-32(25,31)9/h19,23-25,27,34,36H,10-18H2,1-9H3/t19-,23+,24+,25+,27-,30+,31+,32+/m1/s1
InChIKeyYXPPAEOSVBKNSF-PVDPLZRQSA-N
XLogP6.39
TPSA83.83 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms37
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500516.76
LogP ≤ 56.39
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate?
The IUPAC name of [(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate (CID 155521423) is [(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate.
What is the SMILES notation for [(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate?
The canonical SMILES for [(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate is CC(=O)O[C@H]([C@@H](O)C[C@@H](C)C1=C2CC[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1)C(C)(C)O.
What is the InChIKey of [(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate?
The InChIKey is YXPPAEOSVBKNSF-PVDPLZRQSA-N. The full InChI is InChI=1S/C32H52O5/c1-19(18-23(34)27(29(5,6)36)37-20(2)33)21-12-16-31(8)22(21)10-11-25-30(7)15-14-26(35)28(3,4)24(30)13-17-32(25,31)9/h19,23-25,27,34,36H,10-18H2,1-9H3/t19-,23+,24+,25+,27-,30+,31+,32+/m1/s1.
What are the key properties of [(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate?
[(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate has a molecular weight of 516.76 g/mol, XLogP of 6.39, 6 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(3R,4S,6R)-2,4-dihydroxy-2-methyl-6-[(5R,8S,9S,10R,14R)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] acetate is sourced from PubChem (CID 155521423), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).